Safe Software Bolsters Leadership Team with CFO and CPO Appointments to Drive Next Phase of Growth
23.4.2026 16:00:00 EEST | Business Wire | Press release
Safe Software (Safe), creator of FME, the only All-Data, Any-AI enterprise integration platform, today welcomes two executives to its leadership team as it moves into the next phase of growth. Judd Lee has been appointed as the company’s Chief Financial Officer (CFO), and Vanessa Ribreau has been appointed as Chief People Officer (CPO). Having recently crossed $100M in revenue, the expanded leadership team will further enable the company to scale as it accelerates toward its goal of reaching $250M in revenue by 2028.
Judd Lee is a seasoned CFO with over 15 years of experience partnering closely with CEOs to align financial strategy and accelerate sustainable growth. He is known for his strong commitment to mentorship and for building high-performing global teams rooted in trust, morale and a shared sense of purpose. With more than two decades of financial leadership across both private and public companies, Judd has developed a proven track record of scaling businesses and maximizing shareholder value through disciplined execution and strategic insight.
Vanessa Ribreau has spent over a decade scaling People functions at high-growth technology companies, combining business acumen with psychological insight to build systems that enable rapid, sustainable growth. As Chief People Officer at BenchSci, she led the People function through significant organizational expansion while building a remote-first culture that maintained high employee engagement and belonging. She guided AlayaCare through hypergrowth and M&A integration, and partnered with leadership to scale Shopify globally across North America, Europe, and APAC.
“We’re thrilled to welcome Judd and Vanessa at a pivotal time in Safe Software’s growth,” said Don Murray, CEO of Safe Software. “Their leadership will be instrumental as we scale the business and continue to deliver on our mission of helping the world do more with its data. I look forward to the impact they will make as we continue to execute against our long-term strategy to achieve $250M in revenue by 2028.”
Based in Seattle, Judd brings proven expertise in building and scaling finance teams within enterprise SaaS businesses.
“Joining Safe Software at this stage is an exciting opportunity,” said Judd Lee, CFO of Safe Software. “The company has built a strong global presence, and I look forward to working with this talented team to build on that momentum and drive the next phase of growth.”
Canadian people leader Vanessa Ribreau will relocate from Montreal to Vancouver.
"I've spent my career helping technology companies scale without losing what makes them great," said Vanessa Ribreau, CPO of Safe Software. "Safe has something rare: a 30-year legacy of product excellence, a team that genuinely cares about the work, and a growth trajectory that's accelerating. My focus is making sure we build the People systems and culture that allow us to scale to $250M while staying true to what's made Safe successful."
Safe Software recently announced the return of its global user conference, the Peak of Data and AI, taking place March 9–11, 2027, at the QEII Centre in London, UK. For more information visit: peakofdataintegration.com
About Safe Software
Headquartered in Surrey, British Columbia, Safe Software is the creator of FME, the only enterprise integration platform with comprehensive support for spatial data. The company was founded in 1993 and has been focused on bringing life to data since its inception. Whether your challenges have to do with spatial data, big data, stream processing, cloud migration, or business intelligence, Safe Software is here to help you spend more time reaping the benefits of information, and less time fighting it.
For more information, visit safe.com.
About FME by Safe Software
The FME Platform has built-in support for thousands of systems as well as 800+ out-of-the-box transformers allowing users to build and automate custom integration workflows without having to code. Over 20,000 organizations worldwide trust FME technology for their enterprise integration solutions. Through Safe Software’s international partner network, FME is used in 120+ countries around the world and has been localized into multiple languages.
For more information, visit fme.safe.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260423065988/en/
Contacts
Media Contact
Perri Burrage
DGPR
perri.burrage@dg-pr.com
+1 587-577-1337
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release
Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release
Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom